Maravai Lifesciences Holdings (MRVI) Free Cash Flow (2020 - 2026)

Maravai Lifesciences Holdings' Free Cash Flow history runs 7 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 139.06% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at -$55.7 million (down 1084.61% YoY), while the FY2025 annual figure was -$70.7 million, down 1558.49% from the prior year.
• Free Cash Flow for Q1 2026 stood at $4.2 million, up from -$35.0 million in the prior quarter.
• The five-year high for Free Cash Flow was $161.6 million in Q2 2022, with the low at -$35.0 million in Q4 2025.
• The 5-year median for Free Cash Flow is $4.5 million (2024), against an average of $35.1 million.
• The sharpest annual moves came in 2024 and 2025: Free Cash Flow surged 373.63% in 2024, then tumbled 633.96% in 2025.
• Maravai Lifesciences Holdings' Free Cash Flow stood at $108.5 million in 2022, then sank by 49.74% to $54.5 million in 2023, then plunged by 87.98% to $6.6 million in 2024, then sank by 633.96% to -$35.0 million in 2025, then jumped by 112.08% to $4.2 million in 2026.
• Business Quant data shows MRVI's Free Cash Flow at $4.2 million in Q1 2026, -$35.0 million in Q4 2025, and -$8.0 million in Q3 2025.